Skip to main content

Hans-Ewald Hohmeier

Associate Professor in Medicine
Medicine, Endocrinology, Metabolism, and Nutrition
Duke Box 3813, Durham, NC 27710
300 N Duke Street, Durham, NC 27701

Selected Grants


Development of small molecules for islet beta-cell regeneration and diabetes therapy

ResearchInvestigator · Awarded by University of Michigan · 2019 - 2023

Small molecules with pleiotropic positive effects on beta-cell health

ResearchPrincipal Investigator · Awarded by Eli Lilly and Company · 2019 - 2022

Pilot Study: Testing of Comprehensive Mitochondrial Profiling Platform in Islet cells

ResearchPrincipal Investigator · Awarded by Eli Lilly and Company · 2020 - 2022

Biochemical Consequences of Cdka I I Mutation that Result in Unprocessed, Nonfunctional Insulin and Type 2 Diabetes

ResearchCo Investigator · Awarded by Department of Defense · 2016 - 2021

Networks of nutritional stress in human pancreatic islet cells

ResearchInvestigator · Awarded by Merck Sharp & Dohme · 2018 - 2020

Reversible Mitochondrial Protein Acetylation and Metabolic Regulation

ResearchSenior Research Scientist · Awarded by Buck Institute for Research on Aging · 2017 - 2020

Biochemical Mechanisms of NNMT Inhibitors

ResearchResearch Scientist · Awarded by Eli Lilly and Company · 2017 - 2018

HIRN UCSD

ResearchSenior Scientist · Awarded by University of California - San Diego · 2017 - 2018

Physiology of SC-derived Human Beta Cells

ResearchPrincipal Investigator · Awarded by Harvard University · 2016 - 2017

Multi-Disciplinary Approaches to Driving Therapeutic Human Beta Cell Replication

ResearchCo Investigator · Awarded by Mount Sinai School of Medicine · 2013 - 2015

Engineering of Immunoprotection in B-Cell Lines

ResearchCo Investigator · Awarded by National Institutes of Health · 2002 - 2007

External Relationships


  • Diabetologia

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.